We observed significantly reduced tumor volume with deletion of Cxcr2 (360 ± 285mm3) when compared to NRas/Ink4a/Cxcr2WT mice (764 ± 601mm3) (Fig. 2B, p < 0.05, n = 16). This evidence concerns the gene CDKN2A and neoplasm.